-
European responses to the corona crisis - Part 6 (25 April - 30 April)
During the Coronavirus crises, the European Science-Media Hub is collecting and publishing a regular update of the most relevant releases provided by EU institutions and other European and global actors. 🆕 Last Update : 30 April
-
EU Project : CONCISE
CONCISE aims to generate a European-wide debate on science communication, involving a wide array of stakeholders, from media outlets to policy makers, from scientists to business companies, from science communicators to civil society organisations. CONCISE aims at providing qualitative knowledge through... -
CONCISE Project : a European-wide debate on science communication
How do citizens keep themselves informed about the most controversial scientific issues? Which sources of information do they choose? A two-year project aims to answer these questions in order to obtain valuable information on communication to the public, to be taken into account for the near future.
-
The differences between SARS-CoV-1 and SARS-CoV-2
Although according to the World Health Organization the novel coronavirus is primarily transmitted between people through respiratory droplets and contact routes, some scientists suggest we should also consider the possibility of aerosol transmission. As the pandemic continues to unfold, research and...
-
EU Project : COVID-19 Data Portal
Rapid and open sharing of data greatly accelerates research and discovery, which is essential to respond to the COVID-19 pandemic. The European Commission and EMBL’s European Bioinformatics Institute (EMBL-EBI), together with EU Member States and research partners such as ELIXIR, are deploying a dedicated... -
European responses to the corona crisis - Part 5 (18 April - 24 April)
During the Coronavirus crises, the European Science-Media Hub is collecting and publishing a regular update of the most relevant releases provided by EU institutions and other European and global actors. 🆕 Last Update : 24 April
-
Vaccine perspectives for COVID-19 - Interview with Prof. Rino Rappuoli & Prof. Sarah Gilbert
Covid-19 urges policy makers and the big pharma to fasten vaccine developments and possible treatments for the novel coronavirus, SARS-CoV-2. Will the vaccine be specific to Covid-19 only, or will it be suitable for all SARS coronaviruses? Will it be suitable to all ages? What are the greatest challenges...
-
ESMH Press Review, special edition on coronavirus – April 16, 2020
Special edition on coronavirus: check out the ESMH selection of 25 news published in the last 2 weeks on the web.